Frankfurt - Delayed Quote EUR

Synektik Spólka Akcyjna (A2P.F)

53.65
-0.80
(-1.47%)
At close: May 9 at 3:29:02 PM GMT+2
Loading Chart for A2P.F
  • Previous Close 54.45
  • Open 50.35
  • Bid 50.35 x --
  • Ask 57.95 x --
  • Day's Range 50.20 - 53.85
  • 52 Week Range 27.55 - 56.60
  • Volume 60
  • Avg. Volume 0
  • Market Cap (intraday) 468.492M
  • Beta (5Y Monthly) 1.41
  • PE Ratio (TTM) 24.17
  • EPS (TTM) 2.22
  • Earnings Date Jun 11, 2025
  • Forward Dividend & Yield 1.96 (3.66%)
  • Ex-Dividend Date Jan 27, 2025
  • 1y Target Est --

Synektik Spólka Akcyjna provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland. The company sells medical equipment used in diagnostics and therapy, and nuclear medicine. It is also involved in development of IT solutions used in radiology, as well as researches, produces, and sells radiopharmaceutical products used in diagnostics for oncology. In addition, the company operates a research laboratory for diagnostic imaging systems and a service center for medical equipment. Further, it offers maintenance services for medical equipment, as well as acceptance and specialist tests. The company was founded in 2001 and is based in Warsaw, Poland.

www.synektik.com.pl

--

Full Time Employees

September 30

Fiscal Year Ends

Recent News: A2P.F

View More

Performance Overview: A2P.F

Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

A2P.F
39.71%
MSCI WORLD (^990100-USD-STRD)
0.19%

1-Year Return

A2P.F
123.58%
MSCI WORLD (^990100-USD-STRD)
9.31%

3-Year Return

A2P.F
100.94%
MSCI WORLD (^990100-USD-STRD)
0.00%

5-Year Return

A2P.F
100.94%
MSCI WORLD (^990100-USD-STRD)
80.01%

Compare To: A2P.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: A2P.F

View More

Valuation Measures

Annual
As of 5/7/2025
  • Market Cap

    461.52M

  • Enterprise Value

    422.52M

  • Trailing P/E

    24.19

  • Forward P/E

    15.43

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.53

  • Price/Book (mrq)

    8.79

  • Enterprise Value/Revenue

    3.25

  • Enterprise Value/EBITDA

    15.30

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    14.93%

  • Return on Assets (ttm)

    14.72%

  • Return on Equity (ttm)

    42.40%

  • Revenue (ttm)

    556.63M

  • Net Income Avi to Common (ttm)

    83.1M

  • Diluted EPS (ttm)

    2.22

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    187.5M

  • Total Debt/Equity (mrq)

    9.22%

  • Levered Free Cash Flow (ttm)

    41.68M

Research Analysis: A2P.F

View More

Company Insights: A2P.F

Research Reports: A2P.F

View More

People Also Watch